volume 28 issue 5 pages 187-196

RP-HPLC-DAD method development and validation of L-lysine hydrochloride: application to bulk drug substance and multivitamin oral suspension

P R Hemanth Vikram 1, 2
Narasimha M Beeraka 3, 4
Hitesh B. Patel 5
Pramod Kumar 6
2
 
Xenone Healthcare Pvt. Ltd, New Delhi, India
3
 
Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Anantapuramu, India
5
 
Analytical Research and Development, CAPLIN POINT Laboratories Ltd., Chennai, India
6
 
Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-(NIPER)-Guwahati, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India, Guwahati, India
Publication typeJournal Article
Publication date2023-07-09
scimago Q3
wos Q4
SJR0.240
CiteScore1.5
Impact factor1.0
ISSN09491775, 14320517
General Chemistry
General Chemical Engineering
Instrumentation
Safety, Risk, Reliability and Quality
Abstract
L-lysine is an essential amino acid that contains a hydrophobic chain and fewer chromophore groups. Various L-lysine-based products are currently available in the market, and various analytical methods are reported in the literature; but their implementation to analyze L-lysine based products is highly cost-effective and requires considerable efforts to prepare the sample/derivatization. Currently, the developed method is being used to quantify L-lysine hydrochloride in the multivitamin oral suspension production in the pharmaceutical industry. Therefore, the aim of the work was to develop a novel, simple, sensitive, accurate, cost-effective, precise, and robust RP-HPLC-DAD method to quantify L-lysine hydrochloride in bulk drug substances and multivitamin oral suspension using C8 column, which may give more efficiency for amino acid analysis without any derivatization. Optimized mobile phase composition consists of solvent A (phosphate buffer: acetonitrile 95:5 v/v) and solvent B (Phosphate buffer: acetonitrile 5:95 v/v). Buffer pH was adjusted to 2.50 with 3 mol L−1 Orthophosphoric acid. 1-Heptane sulphonic acid anhydrous sodium salt was used as an ion-pairing reagent in the buffer. The detector's wavelength was set at 208 nm with a mobile phase flow rate of 1 mL/minute. Limit of detection ( $${L}_{\mathrm{D}}$$ ) and limit of quantification ( $${L}_{\mathrm{Q}}$$ ) were found to be 17.80 g/mL and 53.94 g/mL, respectively. Excellent recovery was observed in the accuracy analysis of the sample L-lysine hydrochloride. The advantages of this newly developed method are very specific and cost-effective and do not require sample preparation and sample pretreatment. This analysis can be performed with an available C8 column and HPLC–UV detector that proves the cost-effectiveness of the developed method than the currently available analytical methods for the analysis of L-lysine based products.
Found 
Found 

Top-30

Journals

1
Journal of Macromolecular Science - Pure and Applied Chemistry
1 publication, 50%
Natural Product Research
1 publication, 50%
1

Publishers

1
2
Taylor & Francis
2 publications, 100%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2
Share
Cite this
GOST |
Cite this
GOST Copy
Vikram P. R. H. et al. RP-HPLC-DAD method development and validation of L-lysine hydrochloride: application to bulk drug substance and multivitamin oral suspension // Accreditation and Quality Assurance. 2023. Vol. 28. No. 5. pp. 187-196.
GOST all authors (up to 50) Copy
Vikram P. R. H., Beeraka N. M., Patel H. B., Kumar P. RP-HPLC-DAD method development and validation of L-lysine hydrochloride: application to bulk drug substance and multivitamin oral suspension // Accreditation and Quality Assurance. 2023. Vol. 28. No. 5. pp. 187-196.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s00769-023-01544-z
UR - https://doi.org/10.1007/s00769-023-01544-z
TI - RP-HPLC-DAD method development and validation of L-lysine hydrochloride: application to bulk drug substance and multivitamin oral suspension
T2 - Accreditation and Quality Assurance
AU - Vikram, P R Hemanth
AU - Beeraka, Narasimha M
AU - Patel, Hitesh B.
AU - Kumar, Pramod
PY - 2023
DA - 2023/07/09
PB - Springer Nature
SP - 187-196
IS - 5
VL - 28
SN - 0949-1775
SN - 1432-0517
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Vikram,
author = {P R Hemanth Vikram and Narasimha M Beeraka and Hitesh B. Patel and Pramod Kumar},
title = {RP-HPLC-DAD method development and validation of L-lysine hydrochloride: application to bulk drug substance and multivitamin oral suspension},
journal = {Accreditation and Quality Assurance},
year = {2023},
volume = {28},
publisher = {Springer Nature},
month = {jul},
url = {https://doi.org/10.1007/s00769-023-01544-z},
number = {5},
pages = {187--196},
doi = {10.1007/s00769-023-01544-z}
}
MLA
Cite this
MLA Copy
Vikram, P. R. Hemanth, et al. “RP-HPLC-DAD method development and validation of L-lysine hydrochloride: application to bulk drug substance and multivitamin oral suspension.” Accreditation and Quality Assurance, vol. 28, no. 5, Jul. 2023, pp. 187-196. https://doi.org/10.1007/s00769-023-01544-z.